Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2014
10/02/2014WO2014160079A1 Microemulsion topical delivery platform
10/02/2014WO2014160077A1 Compositions to reduce pain comprising an opioid/toll-like receptor 4 antagonist, dextro enantiomers thereof, and methods of use therefor
10/02/2014WO2014160069A1 Compositions and methods for affecting mood states
10/02/2014WO2014160049A1 Topical systems and methods for treating sexual dysfunction
10/02/2014WO2014160026A2 Implantable drug delivery compositions comprising sugar-based sorption enhancers and methods of treatment thereof
10/02/2014WO2014160015A1 Skin tanning using peptides and other compositions
10/02/2014WO2014159987A1 Hair treatment systems and methods using peptides and other compositions
10/02/2014WO2014159851A2 Novel low density lipoprotein nanocarriers for targeted delevery of omega-3 polyunsaturated fatty acids to cancer
10/02/2014WO2014159812A1 Stabilization of essential oils within a hydrocolloid adhesive
10/02/2014WO2014159801A1 Enhanced drug delivery from adhesives
10/02/2014WO2014159778A1 Transdermal drug delivery system containing fentanyl
10/02/2014WO2014159760A1 Liposome oxaliplatin compositions for cancer therapy
10/02/2014WO2014159759A1 Compositions and associated methods for radioisotope-binding microparticles
10/02/2014WO2014159748A1 Transdermal drug delivery system containing donepezil
10/02/2014WO2014159731A1 A topical antiviral composition containing a local anesthetic and method of making the same
10/02/2014WO2014159673A2 Soft oral product
10/02/2014WO2014159662A1 Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
10/02/2014WO2014159659A1 Dental composition comprising chelator and base
10/02/2014WO2014159614A1 Adjuvant and antigen particle formulation
10/02/2014WO2014159604A1 Device for oral delivery of therapeutic compounds
10/02/2014WO2014159582A1 Amphetamine transdermal compositions with acrylic block copolymer
10/02/2014WO2014159573A1 Methylphenidate transdermal compositions with rubber-based adhesives
10/02/2014WO2014159377A1 Compositions containing tanaproget and natural estrogens
10/02/2014WO2014159340A1 Benzonatate modified release solid tablets and capsules
10/02/2014WO2014159275A1 Controlled-release pharmaceutical compositions comprising lamotrigine and methods of producing same
10/02/2014WO2014159060A1 Method of treating infections, diseases or disorders of nail unit
10/02/2014WO2014159051A1 Stable bioactive substances and methods of making
10/02/2014WO2014158965A1 Method and reagent for preparing a diagnostic composition
10/02/2014WO2014158554A1 Process for making hmf from sugars with reduced byproduct formation, and improved stability hmf compositions
10/02/2014WO2014158201A1 Compositions, formulations and methods of bio-balancing the ph of sterile isotonic saline and hypertonic saline solutions
10/02/2014WO2014158119A1 Aqueous solution composition containing ipratropium and oxymetazoline
10/02/2014WO2014158118A1 Suspension composition containing ipratropium and oxymetazoline
10/02/2014WO2014158033A1 Stabilized vitamin d formulations
10/02/2014WO2014157989A1 Stabilized composition containing voriconazole
10/02/2014WO2014157852A1 Sustained-release medicinal composition containing eperisone as active ingredient
10/02/2014WO2014157752A1 Method for manufacturing emulsion bead by low-temperature cooling, and emulsion bead yielded thereby
10/02/2014WO2014157603A1 Pharmaceutical composition for oral administration
10/02/2014WO2014157484A1 Tablet for preparing solution of chlorine dioxide
10/02/2014WO2014157264A1 Film-coated orally disintegrating tablet
10/02/2014WO2014157137A1 Oral administration preparation with masked bitterness of silodosin
10/02/2014WO2014156958A1 Nano-capsule, composition, polynucleotide, recombinant vector, and transformant
10/02/2014WO2014156505A1 Jelly-like tablet and jelly-like lozenge using same
10/02/2014WO2014155397A1 Oral suspension for treating eosinophilic esophagitis
10/02/2014WO2014155373A1 Nutritional supplement for growth enhancement
10/02/2014WO2014155370A1 Kit with multiple nutritional supplements and a method for assembling thereof
10/02/2014WO2014155284A1 Tablet comprising fructose
10/02/2014WO2014155261A1 Microencapsulation of oxygen liberating reactants
10/02/2014WO2014155142A1 Stable nanocomposition comprising doxorubicin, process for the preparation thereof, its use and pharmaceutical compositions containing it
10/02/2014WO2014155134A1 Use of stearate in an inhalable formulation
10/02/2014WO2014155103A1 Taurine compositions suitable for inhalation
10/02/2014WO2014155074A1 Composition
10/02/2014WO2014154804A1 Pharmaceutical formulation for use in the treatment and/or prevention of restenosis
10/02/2014WO2014154677A1 Composition for the treatment of disease
10/02/2014WO2014154643A1 Extended release formulations of metformin
10/02/2014WO2014154640A1 Controlled-release formulations comprising metformin and gliclazide
10/02/2014WO2014154531A1 Semifluorocarbon compound containing contrast agent
10/02/2014WO2014154203A2 Fusion mixture
10/02/2014WO2014154029A1 Composite structural material and pharmaceutical composition thereof
10/02/2014WO2014153733A1 Ophthalmic composition, method for preparing the same, and use of the same
10/02/2014WO2014153687A1 Cosmetic mask
10/02/2014WO2014153685A1 Chinese medicine capsule for treating lupus erythematosus
10/02/2014US20140296836 Gold-in-silicon nanoassembly for thermal therapy and methods of use
10/02/2014US20140296826 Preparation patch and safety syringe system
10/02/2014US20140296799 Degradable Removable Implant for the Sustained Release of An Active Compound
10/02/2014US20140296541 Orthoester compound
10/02/2014US20140296353 Prion free nanoparticle compositions and methods of making thereof
10/02/2014US20140296351 Pharmaceutical formulation
10/02/2014US20140296336 Solid retard formulations based on solid dispersions
10/02/2014US20140296328 High concentration olopatadine ophthalmic composition
10/02/2014US20140296322 Conjugates, particles, compositions, and related methods of use
10/02/2014US20140296309 Modified release compositions of epalrestat or a derivative thereof and methods for using the same
10/02/2014US20140296303 Use of Pyridoxamine to Treat and/or Prevent Disease Processes
10/02/2014US20140296301 Topical ophthalmological pharmaceutical composition containing regoragenib
10/02/2014US20140296293 Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat
10/02/2014US20140296279 Intravascular delivery of nanoparticle compositions and uses thereof
10/02/2014US20140296277 Pharmaceutical preparation containing oxycodone and naloxone
10/02/2014US20140296276 Sequestered antagonist formulations
10/02/2014US20140296267 Solid dispersions of a erb2 (her2) inhibitor
10/02/2014US20140296197 Combinations comprising antimuscarinic agents and beta-adrenergic agonists
10/02/2014US20140296192 Pharmaceutical composition for use in nasal administration containing corticoid, and a quinolone or fusidic acid
10/02/2014US20140296191 Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives
10/02/2014US20140296189 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
10/02/2014US20140296158 Sustained action formulation of cyclosporin form 2
10/02/2014US20140295003 Methods for improving health in canines
10/02/2014US20140295002 Methods for improving health in humans
10/02/2014US20140294996 One or more of vigna marina, cocos nucifera l. or terminalia catappa l. extracts for treating wounds, skin disorders and hair loss
10/02/2014US20140294995 Lozenge for treating sore throat, hoarseness and associated dry cough, and inflammatory diseases of the oral and pharyngeal cavity
10/02/2014US20140294986 Microsphere Drug Delivery System for Sustained Intraocular Release
10/02/2014US20140294984 Compacted rumen protected nutrient pellets and method of manufacture
10/02/2014US20140294983 Stable nanocomposition comprising doxorubicin, process for the preparation thereof, its use and pharmaceutical compositions containing it
10/02/2014US20140294982 Nanoparticle compositions for generation of regulatory t cells and treatment of autoimmune diseases and other chronic inflammatory conditions
10/02/2014US20140294981 Carbon encapsulated transition metal oxide nanocomposite, a method for its preparation and its use in li-ion batteries
10/02/2014US20140294980 Sustained release particle formulations
10/02/2014US20140294973 Pharmaceutical compositions of hydrophobic camptothecin derivatives
10/02/2014US20140294971 Cancer cell-inhibiting ceramic, process for producing cancer cell-inhibiting ceramic, method for treating bone tumor, and use of beta-tricalcium phosphate porous granules with particle size of 1 to 10 micrometer
10/02/2014US20140294970 Stabilized pharmaceutical sub-micron suspensions and methods of forming same
10/02/2014US20140294969 Method and formulation for inhalation
10/02/2014US20140294964 Compositions and methods for treating cancer with dacarbazine nanoemulsions
10/02/2014US20140294961 Hepatic protection agent containing eggshell membrane and pharmaceutical composition, food additive and food using the same
10/02/2014US20140294959 Pharmaceutical Composition of Rosuvastatin Calcium
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 2991